XBiotech Inc. — Cash Flow Charts
20 quarters of history · ending 2023-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+6.1% +$315K
$-5M
Free Cash Flow↑+12.9% +$17K
$-115K
Investing Cash Flow
$62M
Financing Cash Flow
$0
Capex↓-12.9% -$17K
$115K
Stock Buybacks
$0
Dividends Paid
$0
Stock-Based Comp↓-33.7% -$350K
$688K
D&A↓-12.0% -$53K
$390K
SBC Allocated Expense↓-33.7% -$350K
$688K